Solventum Corp. logo

Solventum Corp.(SOLV)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
3-STAR RATING
PASS
LAST CLOSE
$85.8
11/19/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SOLV

11/19/2026: SOLV (3-star) is currently NOT-A-BUY. Pass it for now.

Solventum Corp. is a global healthcare company specializing in medical-surgical supplies, dental solutions, and health information systems following its 2024 spin-off from 3M. The company's main strengths include trusted legacy brands, robust gross profit margins, and essential consumable product franchises like V.A.C.® Therapy. Its core investment narrative centers on portfolio optimization, margin enhancement, and selective bolt-on acquisitions in advanced wound care. However, key risks involve integration and separation friction, moderate organic growth rates, and hospital pricing pressures. Solventum suits value-oriented investors seeking defensive healthcare exposure while monitoring execution on strategic portfolio reviews.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitSolventum offers low-single-digit organic revenue growth, appealing more to turnaround or operational-improvement strategies than high-beta growth seekers.
Momentum investorMixed fitMomentum fit depends on sustained positive breakouts following portfolio reshaping and clearer earnings predictability.
Value investorStrong fitThe stock trades at reasonable earnings multiples relative to diversified healthcare peers as it executes its standalone transformation.
Dividend investorWeak fitThe company currently prioritizes debt reduction and operational reinvestment over returning capital via robust dividends.
Low-risk investorMixed fitWhile healthcare demand is defensive, post-spinoff execution risks and operational restructuring create moderate near-term volatility.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumPost-spinoff restructuring and transition milestones can trigger short-term equity price fluctuations.
Valuation riskLowCurrent market valuations account for near-term headwinds and post-spin transition adjustments.
Competition risk (healthcare equipment and informatics competition)Medium / highIntense competition from established medtech leaders puts pressure on pricing and hospital contracts.
Business qualityStrongThe company features high gross margins and sticky, mission-critical healthcare consumable franchises.
Dividend incomeLow / noneIncome-focused investors will find limited immediate dividend yield as capital is retained for growth.
Execution riskMedium / highSuccessfully executing IT separation, ERP cutovers, and potential business divestitures is vital to margin goals.

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 14.70B USD
Price to earnings Ratio 97.17
1Y Target Price 98.38
Price to earnings Ratio 97.17
1Y Target Price 98.38
Volume (30-day avg) 1.2M shares
Beta 0.75
52 Weeks Range 62.38 - 94.16
Updated Date 11/19/2026
52 Weeks Range 62.38 - 94.16
Updated Date 11/19/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.89

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
61.0%
Active BUY / eligible
64 / 105
30-Day BUY Count Change
+16
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Instruments & Supplies

BUY participation
40.0%
Active BUY / eligible
2 / 5
30-Day BUY Count Change
0

Eligible universe: 5 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 13.57%
Avg. Invested days 48
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/19/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SOLV receives a 4-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
SOLV has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and strong ownership. In FY2025 versus FY2024, strong earnings growth (+224.8%) and solid profitability (net margin 18.7%) are partially offset by weak cash generation (FCF margin -0.1%), moderate revenue growth (+0.9%).

Financial Health Rating

★★★★★
SOLV's financial health is supported by solid profitability, including gross margin of 53.5% and operating margin of 26.2%. Liquidity is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is SOLV's strongest growth driver at +224.8% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (+0.9%, moderate) and free-cash-flow growth (-101.2%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 76.9% and approximately 84.5% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 15.37% supports management-shareholder alignment.

Top 5 Institutional Investors

Independent Franchise Partners LLP 9.23%
BlackRock Inc 5.75%
Vanguard Capital Management, LLC 5.67%
Trian Fund Management LP 4.85%
Vanguard Portfolio Management, LLC 3.73%

Unit Economics (Per $1K Revenue)

★★★★★
SOLV generates approximately $535 of gross profit, $262 of operating income, and $-1 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins and weak cash conversion support a 3-star rating, while capital efficiency is strong.

Economic Dimensions

★★★★★
Effective Tax Rate: 9.17%

Quantitative Style Profile

★★★★★
SOLV has a large-cap, liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilityLarge / Mega Cap StabilityHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
MedSurgAdvanced wound care, infection prevention, surgical tapes, and patient monitoring products sold globally.This is the company's largest revenue engine, providing steady, consumable-driven cash flows from hospitals.
Dental SolutionsRestorative composites, orthodontic brackets, aligners, and preventive dental consumables.Provides steady exposure to dental practices and elective dental procedures.
Health Information SystemsSoftware solutions for clinical documentation, medical coding automation, and revenue cycle management.Offers technology-driven recurring software revenue streams supporting hospital efficiency.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When After Market
Estimate 1.35
Actual 1.45

Profitability

Profit Margin 1.91%
Operating Margin (TTM) 5.91%

Management Effectiveness

Return on Assets (TTM) 2.14%
Return on Equity (TTM) 3.19%

Valuation

Trailing PE 97.17
Forward PE 11.51
Enterprise Value 19.43B
Price to Sales(TTM) 1.8
Enterprise Value 19.43B
Price to Sales(TTM) 1.8
Enterprise Value to Revenue 2.38
Enterprise Value to EBITDA 20.76
Shares Outstanding 169.96M
Shares Floating 143.61M
Shares Outstanding 169.96M
Shares Floating 143.61M
Percent Insiders 15.37
Percent Institutions 76.88

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.